Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids -: mRNA analysis and promoter characterization

被引:60
作者
Paul, C
Seiliez, I
Thissen, JP
Le Cam, A
机构
[1] Hop Arnaud de Villeneuve, INSERM, U376, F-34295 Montpellier 05, France
[2] Univ Louvain, Sch Med, Nutr & Diabet Unit, Brussels, Belgium
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 19期
关键词
SOCS; hepatocytes; glucocorticoids; interleukin-6; growth hormone;
D O I
10.1046/j.1432-1327.2000.01395.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppressors of cytokine signalling (SOCS) represent a newly discovered family of molecules that seem to play an important role in the shutting off of cytokine and possibly peptide hormone action. Thus, understanding the mechanisms controlling their expression is of cardinal importance. In the present study, we have cloned the rat SOCS-3 gene and analyzed its expression and the functioning of its promoter in hepatocytes. Expression of SOCS-3 mRNA, which is very weak in freshly isolated cells, tended to increase when hepatocytes were incubated without hormones. Growth hormone (GH) and, to a much larger extent, interleukin-6 (IL-6) rapidly activated mRNA synthesis whereas glucocorticoids (GC) strongly inhibited both basal and hormone-dependent expressions. A short promoter fragment (-137/+35) responded maximally to GH and IL-6 (a threefold stimulation for each effector) and to GC (a 70-80% inhibition), whereas longer promoter sequences supported higher basal activity and lower positive hormonal responses. Deletion and mutation analyses indicated that all hormonal responses were dependent on two cis-acting sequences termed the G-rich and the A/T-rich elements. Only the A/T-rich element was active in a heterologous context, thus behaving as a typical enhancer. Unexpectedly, the two signal transducer and activator of transcription (STAT) binding sites found immediately upstream of the G-rich motif didn't seem to participate in either GH or IL-6 effect, despite the fact that one of them strongly responded to IL-6 when placed in front of a heterologous promoter. Finally, the negative regulation of SOCS-3 promoter by GC that may contribute to gene silencing in vivo, appeared to involve interactions of the GC receptor with other transcription factors and not direct binding to DNA, as no GC-response element was found in the sequence.
引用
收藏
页码:5849 / 5857
页数:9
相关论文
共 41 条
[1]   Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling [J].
Adams, TE ;
Hansen, JA ;
Starr, R ;
Nicola, NA ;
Hilton, DJ ;
Billestrup, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1285-1287
[2]   Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter [J].
Auernhammer, CJ ;
Bousquet, C ;
Melmed, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6964-6969
[3]   Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes [J].
Beauloye, V ;
Ketelslegers, JM ;
Moreau, B ;
Thissen, JP .
GROWTH HORMONE & IGF RESEARCH, 1999, 9 (03) :205-211
[4]   Definition of a high affinity growth hormone DNA response element [J].
Bergad, PL ;
Towle, HC ;
Berry, SA .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 150 (1-2) :151-159
[5]  
Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]   Specific inhibition of Stat3 signal transduction by PIAS3 [J].
Chung, CD ;
Liao, JY ;
Liu, B ;
Rao, XP ;
Jay, P ;
Berta, P ;
Shuai, K .
SCIENCE, 1997, 278 (5344) :1803-1805
[8]  
Cohney SJ, 1999, MOL CELL BIOL, V19, P4980
[9]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[10]   STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver [J].
Davey, HW ;
McLachlan, MJ ;
Wilkins, RJ ;
Hilton, DJ ;
Adams, TE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 158 (1-2) :111-116